$150k - $250k
Estimated savings per avoided physical DOE run
Maximizing Asset Value
The Simulator equips biotech innovators with actionable process data earlier in development, so candidates are backed by stronger evidence than theoretical potential. With more robust data packages and readiness for immediate process development, companies can present higher asset value during funding activities.
- Stress-Testing Workflows: Anticipate risks and validate approaches virtually.
- Digital Process Development: Test individual unit operations iteratively.